• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Urology Times Media Information

Article

Urology Times takes the lead in providing news analysis of key advances in surgical and non-surgical techniques, treatments and practice management. As the #1 read publication reaching the full universe of specialists treating urologic disorders, Urology Times keeps urologists up to date so they can quickly provide better patient care while running a more efficient business.

  • Ranked #1 in Readership and Exposures (Mars Fall ’08)



For Advertising, Custom Programs, and Web:Samantha Armstrong
National Sales Manager
732-346-3083
sarmstrong@advanstar.com

For Classifieds, Product & Service Showcase and Web:Michele Cohen
Marketing Advisor
440-891-2627
mcohen@advanstar.com

For Recruitment, Enews and Web:Scott Eigenbrod
Marketing Advisor
440-891-2671
seigenbrod@advanstar.com

For Lists:Renee Schuster
Marketing Advisor
440-891-2613
rschuster@advanstar.com

For contracts, insertions orders, other instructions,publication-set copy, reproduction materials, electronic file disks andproofs:Sheila Markes
Production Manager
218-740-6509
smarkes@advanstar.com

For detailed digital ad specifications and to submit your materials, click here.

Print Solutions:

Multimedia Solutions:

Related Videos
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Gamal M. Ghoniem, MD, FACS, ABU/FPMRS, gives an answer during a video interview
Edward M. Schaeffer, MD, PhD, answers a question during a Zoom video interview
Zhina Sadeghi, MD, answers a question during a video interview
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
A panel of 4 experts on prostate cancer
© 2024 MJH Life Sciences

All rights reserved.